Celiac disease: mechanisms and emerging therapeutics

Area of Science:

• Immunology
• Gastroenterology
• Autoimmune Diseases

Background:

• Celiac disease (CeD) is a prevalent autoimmune disorder triggered by gluten ingestion.
• Currently, no medicinal therapies exist for CeD, leaving dietary changes as the only management option.
• Understanding the molecular basis of CeD is crucial for developing alternative treatments.

Purpose of the Study:

• To review the current understanding of celiac disease pathogenesis.
• To explore how this knowledge can be applied to therapeutic design and development for non-dietary treatments.

Main Methods:

• Review of existing scientific literature on celiac disease.
• Analysis of the molecular and cellular mechanisms underlying CeD.
• Examination of potential therapeutic targets within the identified pathogenic pathways.

Main Results:

• A model of CeD pathogenesis involving interactions between MHC class II proteins, deamidated gluten peptides, and T cell receptors (TCRs) has been established.
• This pathogenic axis presents a viable target for pharmacological intervention.
• Additional host and environmental factors contributing to disease initiation and progression have been identified.

Conclusions:

• Targeting the key molecular interactions in CeD pathogenesis offers a promising strategy for developing non-dietary therapies.
• Further research into host and environmental factors may reveal additional therapeutic avenues.
• The development of medicinal treatments for CeD is an active and evolving area of research.